1. Home
  2. CELU vs HLP Comparison

CELU vs HLP Comparison

Compare CELU & HLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • HLP
  • Stock Information
  • Founded
  • CELU 2016
  • HLP 2021
  • Country
  • CELU United States
  • HLP China
  • Employees
  • CELU N/A
  • HLP N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • HLP Industrial Machinery/Components
  • Sector
  • CELU Health Care
  • HLP Industrials
  • Exchange
  • CELU Nasdaq
  • HLP Nasdaq
  • Market Cap
  • CELU 64.3M
  • HLP 52.1M
  • IPO Year
  • CELU N/A
  • HLP 2023
  • Fundamental
  • Price
  • CELU $2.15
  • HLP $1.01
  • Analyst Decision
  • CELU Strong Buy
  • HLP
  • Analyst Count
  • CELU 1
  • HLP 0
  • Target Price
  • CELU $6.00
  • HLP N/A
  • AVG Volume (30 Days)
  • CELU 136.2K
  • HLP 193.1K
  • Earning Date
  • CELU 08-29-2025
  • HLP 09-19-2025
  • Dividend Yield
  • CELU N/A
  • HLP N/A
  • EPS Growth
  • CELU N/A
  • HLP N/A
  • EPS
  • CELU N/A
  • HLP N/A
  • Revenue
  • CELU $44,590,000.00
  • HLP $14,105,620.00
  • Revenue This Year
  • CELU N/A
  • HLP N/A
  • Revenue Next Year
  • CELU $76.00
  • HLP N/A
  • P/E Ratio
  • CELU N/A
  • HLP N/A
  • Revenue Growth
  • CELU 4.45
  • HLP N/A
  • 52 Week Low
  • CELU $1.00
  • HLP $0.61
  • 52 Week High
  • CELU $5.22
  • HLP $1.95
  • Technical
  • Relative Strength Index (RSI)
  • CELU 34.61
  • HLP 77.19
  • Support Level
  • CELU $2.05
  • HLP $0.64
  • Resistance Level
  • CELU $2.41
  • HLP $0.97
  • Average True Range (ATR)
  • CELU 0.30
  • HLP 0.07
  • MACD
  • CELU -0.10
  • HLP 0.03
  • Stochastic Oscillator
  • CELU 6.57
  • HLP 92.52

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About HLP Hongli Group Inc.

Hongli Group Inc is a cold roll-formed steel profile manufacturer in China. It customizes and manufactures cold roll-formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation. Geographically, the company generates the majority of its revenue from the PRC.

Share on Social Networks: